BioRich Posted - 2 days ago

$CRMD $ARVN $TRVI and $ARRNF victims of pullback. Still great investments both short-term (weeks/months) and long-term

BioRich Posted - 1 week ago

$OCGN $SLS $VRNA $TRVI and $SRPT expected to close the week strong.

m97531 Posted - 1 week ago

$TRVI Any technical analyst here to explain this drop ? Any fundamentalist ? Cheers

BioRich Posted - 1 week ago

$TRVI $CRMD $CANF were quiet for a bit but are starting to get attention. Buy and hold.

Stock_Titan Posted - 1 week ago

$TRVI Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference https://www.stocktitan.net/news/TRVI/trevi-therapeutics-announces-abstract-presentation-at-the-american-pcb11i6kk0ds.html

NMWOLF Posted - 1 week ago

$TRVI Added ! Dp flows and great set up with golden cross on the daily. Seems news pending ? Inst buying to

NMWOLF Posted - 1 week ago

$TRVI easy money here. Added. Holden cross setup as well as DP buys coming in !💎

BioRich Posted - 1 week ago

$VRNA wake up every morning hoping for news. $TRVI should keep climbing and hoping for a $LUNR bounce back

BioRich Posted - 2 weeks ago

$ADXN great movement! Get in while you can and let's squeeze these shorties! $VRNA and $TRVI looking good to close the week as well!

BioRich Posted - 2 weeks ago

$TRVI upcoming events. $LLY $RYTM news soon hopefully.

Stock_Titan Posted - 2 weeks ago

$TRVI Trevi Therapeutics to Participate in Upcoming April Events https://www.stocktitan.net/news/TRVI/trevi-therapeutics-to-participate-in-upcoming-april-8xa4573l3vah.html

commoncentsinvestor Posted - 2 weeks ago

$TRVI SHOULD BE BIG WINNER Anyone looking for a stock that could have a big increase in share price in 2024 might want to take a look at CVRX. They got FDA approval for its Barostim product to improve the lives of people suffering from heart failure back in 2019. They have spent the last 4 years building a market for their product and it is about to reap big rewards. They have been increasing their revenues, the number of implant centers, their territories, , and their public visibility by leaps and bounds and work on 84% gross margins. This should all result in big increases in revenues and share price this year. I expect a minimum of $65M in 2024 revenues and with 84% Gross Margins, a 15 times Market Cap would be very reasonable. That would put the share price at about $47. Current Share Price is under $18. With only 600 followers on Stock Twits, it is very early in the game for folks who like to invest in under followed small companies with HUGE potential.

BioRich Posted - 2 weeks ago

$TRVI nice opportunity to buy along with $TERN $VTGN and $CRMD before the post-lunch bounce. Don't forget about $SRPT

Karanjot Posted - 03/29/24

$TRVI 🔥🔥🔥💯💯

Karanjot Posted - 03/29/24

$TRVI

Tmctague Posted - 03/25/24

$TRVI Good old Robinhood. Price is $3.27 on all other channels.

MadMaverick Posted - 03/21/24

$CHRO Super Low Float. Does not take much vol to get this moving. Waiting for confirmation above $3.00 Demand zone is HERE. Recent news out today 👇🏼 https://finance.yahoo.com/news/chromocell-announces-formal-launch-eye-123000840.html $LU $TRVI $AMTX $AAPL Communicated - Disclaimer

m97531 Posted - 4 weeks ago

$TRVI Any one had a chance to listen to earning call ? Anything mentioned about how many patients have been registered into river program ( RCC) so far ? Thx

epsguid Posted - 4 weeks ago

$TRVI reported a loss of $0.08, consensus was ($0.10) via @eWhispers #epsbeat http://eps.sh/d/trvi

DonCorleone77 Posted - 4 weeks ago

$TRVI Trevi Therapeutics reports Q4 EPS (8c), consensus (9c) "I am proud of the progress Trevi has made in 2023, with the initiation of clinical trials in the fourth quarter for RCC, chronic cough in IPF, and the final part of the Human Abuse Potential (HAP) study," said Jennifer Good, CEO. "All three of these trials are enrolling patients and we reaffirm our guidance to read out topline data in the second half of this year for the RCC trial and the HAP study. During this time, we also plan to complete and release the results of the sample size re-estimation for the chronic cough in IPF trial. We are expecting 2024 to be a milestone year of important data readouts in areas of chronic cough where there is a significant unmet need with no approved treatments in the U.S."

Stock_Titan Posted - 4 weeks ago

$TRVI Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates https://www.stocktitan.net/news/TRVI/trevi-therapeutics-reports-fourth-quarter-and-year-end-2023-7950aq3cfeau.html

Riqhavok Posted - 1 month ago

$TRVI Its crazy barely 1000 people are watching this.

m97531 Posted - 1 month ago

$TRVI Any one here knows technical analysis ?

Stock_Titan Posted - 1 month ago

$TRVI Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024 https://www.stocktitan.net/news/TRVI/trevi-therapeutics-to-report-q4-and-year-end-2023-financial-results-nqlvwqkoxk0p.html